Day: March 21, 2025

MELBOURNE, Australia and INDIANAPOLIS, March 21, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has approved its New Drug Application (NDA) for Gozellix® (TLX007-CDx, kit for the preparation of gallium-68 (68Ga) gozetotide injection), Telix’s next-generation PSMA-PET imaging1 agent for prostate cancer. Gozellix®, after radiolabeling with 68Ga, is indicated for PET scanning of PSMA positive lesions in men with prostate cancer who have suspected metastasis and are candidates for initial definitive therapy, and those with suspected recurrence based on elevated serum prostate-specific antigen (PSA) level. Gozellix® is a novel product which provides a longer shelf life of up to six hours and an extended...

Indkaldelse til ordinær generalforsamling den 23. april 2025 er vedhæftet.Med venlig hilsen PARKEN Sport & Entertainment A/SLars Ypkendanz CFOAttachment08-2025 Indkaldelse til OGF 2025

In connection with Borregaard’s Annual General Meeting, Mr. Helge Aasen, Chair of the Board of Directors in Borregaard ASA, has been assigned voting rights based on proxies for 7,137,969 shares in Borregaard ASA. The proxies apply exclusively to the Annual General Meeting in Borregaard ASA on 10 April 2025. This means that Mr. Helge Aasen represents a total of 7,14 % of the outstanding shares in Borregaard ASA. Mr. Helge Aasen’s shareholding in Borregaard ASA is 4,500 shares. Borregaard ASASarpsborg, 21 March 2025 Contact: Lotte Kvinlaug, Investor Relations Officer, +47 922 86 909 This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.

OSLO, Norway (21 March 2025) – TGS, a leading global provider of energy data and intelligence, published its 2024 annual report today.  In addition, TGS has published its 2024 Management Remuneration Report (MRR) according to the Norwegian Public Limited Liability Companies Act, section 6-16b (2). The 2024 annual report and the MRR are available on the TGS’ website https://www.tgs.com. The Annual Report has also been published in European Single Electronic Format (ESEF) and can be downloaded from TGS.com (http://www.tgs.com) or www.newsweb.no.About TGSTGS provides advanced data and intelligence to companies active in the energy sector. With leading-edge technology and solutions spanning the entire energy value chain, TGS offers a comprehensive range of insights to help clients make better decisions. Our broad range of products...

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Investec Bank plc(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Niox Group plc(c)        Name of the party to the offer with which exempt principal trader is connected: Investec is Joint Broker to Niox Group plc(d)        Date dealing undertaken: 20th March 2025(e)        In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?         If it is a cash offer or possible cash offer, state...